BusinessGE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and DeliveryBy Nasdaq OMXJun 20, 2017, 11:30 AM UTC
BusinessAXIM® Biotechnologies Secures Funding to Advance Clinical Trials and Bioequivalency StudyBy Nasdaq OMXJun 19, 2017, 1:00 PM UTC
BusinessEarth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit IncreaseBy Nasdaq OMXJun 19, 2017, 12:15 PM UTC
BusinessAXIM Biotech to Present at 2017 Marcum Microcap Conference in New York CityBy Nasdaq OMXJun 14, 2017, 1:00 PM UTC
BusinessLeading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing MarketBy Nasdaq OMXJun 7, 2017, 3:14 PM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
